Assignee
SIVIDON DIAGNOSTICS GMBH
DE·1 granted patent·3 pending applications·0 citations·filing 2009–2017
Top patents by PatentIndex Score
4 records- 0152US2017081728A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2016·Application pending·0 cites
- 0250US2011166845A1Method for the quality assessment of nucleic acid amplification reactionsSIVIDON DIAGNOSTICS GMBH·Filed 2009·Application pending·0 cites
- 0348US10301685B2Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2017·Granted May 28, 2019·0 cites·10 claims
- 0447US2015376714A1Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancerSIVIDON DIAGNOSTICS GMBH·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SIVIDON DIAGNOSTICS GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →